表紙
市場調查報告書

迷走神經刺激設備:開發平台分析

Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 345364
出版日期 內容資訊 英文 121 Pages
訂單完成後即時交付
價格
Back to Top
迷走神經刺激設備:開發平台分析 Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月16日內容資訊: 英文 121 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的迷走神經刺激設備開發中產品資訊相關分析,提供您臨床實驗與產品開發的進展,彙整各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品的詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 迷走神經刺激設備概要

第3章 開發中的產品

  • 迷走神經刺激設備 - 各開發階段的開發中產品
  • 迷走神經刺激設備 -國家 (地區) 別的開發中產品
  • 迷走神經刺激設備 - 法規別開發中產品
  • 迷走神經刺激設備 - 各認證時期 (估計) 的開發中產品
  • 迷走神經刺激設備 - 現在進行中的臨床實驗

第4章 迷走神經刺激設備 - 正在開發的開發中產品:各企業

  • 迷走神經刺激設備企業 - 各開發階段的開發中產品
  • 迷走神經刺激設備 - 各開發階段的開發中產品

第5章 迷走神經刺激設備企業與產品概要

  • BioControl Medical
  • Boston Scientific Corporation
  • CerboMed GmbH
  • Cerebral RX Ltd.
  • Children's Hospital Boston
  • Cyberonics, Inc.
  • DuoCure Ltd.
  • ElectroCore, LLC
  • Medical University of South Carolina
  • MicroTransponder Inc.
  • Neurostream Technologies G.P.
  • Setpoint Medical Corporation
  • Sorin S.p.A.
  • Trifectas Medical Corp.

第6章 迷走神經刺激設備 - 最近的趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0848EPD

GlobalData's Medical Devices sector report, "Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2019" provides an overview of Vagus Nerve Stimulators (VNS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vagus Nerve Stimulators (VNS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vagus Nerve Stimulators (VNS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vagus Nerve Stimulators (VNS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vagus Nerve Stimulators (VNS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Vagus Nerve Stimulators (VNS) Overview 8

3 Products under Development 9

  • 3.1 Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development 9
  • 3.2 Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory 10
  • 3.3 Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path 11
  • 3.4 Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date 12
  • 3.5 Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials 13

4 Vagus Nerve Stimulators (VNS) - Pipeline Products under Development by Companies 14

  • 4.1 Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development 14
  • 4.2 Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development 15

5 Vagus Nerve Stimulators (VNS) Companies and Product Overview 17

  • 5.1 Aucta Technologies Inc Company Overview 17
    • 5.1.1 Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.2 Boston Scientific Corp Company Overview 20
    • 5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.3 Cala Health Inc Company Overview 24
    • 5.3.1 Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.4 CerboMed GmbH Company Overview 25
    • 5.4.1 CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.5 Cyberonics Inc Company Overview 26
    • 5.5.1 Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.6 DuoCure Ltd. Company Overview 27
    • 5.6.1 DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.7 ElectroCore Inc Company Overview 28
    • 5.7.1 ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.8 LivaNova PLC Company Overview 33
    • 5.8.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.9 Medical University of South Carolina Company Overview 42
    • 5.9.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.10 MicroTransponder Inc Company Overview 43
    • 5.10.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.11 Nexeon MedSystems Inc Company Overview 48
    • 5.11.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.12 Otto Bock HealthCare GmbH Company Overview 50
    • 5.12.1 Otto Bock HealthCare GmbH Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.13 Parasym Ltd Company Overview 52
    • 5.13.1 Parasym Ltd Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.14 Pulsus Medical LLC (Inactive) Company Overview 55
    • 5.14.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.15 Purdue University Company Overview 56
    • 5.15.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.16 Setpoint Medical Inc Company Overview 57
    • 5.16.1 Setpoint Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.17 Synergia Medical Company Overview 60
    • 5.17.1 Synergia Medical Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.18 SzeleSTIM GmbH Company Overview 61
    • 5.18.1 SzeleSTIM GmbH Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.19 The Feinstein Institute for Medical Research Company Overview 62
    • 5.19.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.20 Trifectas Medical Corp. Company Overview 67
    • 5.20.1 Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.21 University of Pittsburgh Company Overview 68
    • 5.21.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.22 University of Wisconsin Madison Company Overview 69
    • 5.22.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 69

6 Vagus Nerve Stimulators (VNS)- Recent Developments 70

  • 6.1 Nov 13, 2019: electroCore announces third quarter 2019 financial results 70
  • 6.2 Oct 30, 2019: LivaNova reports third quarter 2019 results 71
  • 6.3 Oct 29, 2019: SetPoint Medical announces oral presentation of results from U.S. pilot study in rheumatoid arthritis patients at American College of Rheumatology (ACR) Annual Meeting 2019 72
  • 6.4 Oct 23, 2019: Study published in Neurology shows chronic epilepsy associated with marker of cardiac electrical instability 72
  • 6.5 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 73

7 Appendix 118

  • 7.1 Methodology 118
  • 7.2 About GlobalData 121
  • 7.3 Contact Us 121
  • 7.4 Disclaimer 121

List of Tables

  • Table 1: Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
  • Table 2: Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
  • Table 3: Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
  • Table 4: Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
  • Table 5: Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
  • Table 6: Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
  • Table 7: Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
  • Table 8: Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: DECIMA Device - Product Status
  • Table 10: DECIMA Device - Product Description
  • Table 11: Aucta Technologies Inc - Ongoing Clinical Trials Overview
  • Table 12: DECIMA Device - This is a Single-site, Double-blind, Randomized, Prospective, Sham-controlled, Crossover Early Feasibility Study to Determine Whether Ultrasound Vagus Nerve Stimulation (uVNS) Inhibits Postprandial Hyperglycemia in Humans
  • Table 13: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: AMT System - Product Status
  • Table 15: AMT System - Product Description
  • Table 16: Vagus Nerve Stimulation (VNS) System - Product Status
  • Table 17: Vagus Nerve Stimulation (VNS) System - Product Description
  • Table 18: Boston Scientific Corp - Ongoing Clinical Trials Overview
  • Table 19: Vagus Nerve Stimulation (VNS) System - Neural Cardiac Therapy for Heart Failure Study
  • Table 20: Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Wearable Neuromodulation Device - Product Status
  • Table 22: Wearable Neuromodulation Device - Product Description
  • Table 23: CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: t-VNS - Dementia - Product Status
  • Table 25: t-VNS - Dementia - Product Description
  • Table 26: Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Nerve Wrap - Product Status
  • Table 28: Nerve Wrap - Product Description
  • Table 29: DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Intraluminal Implantable Device - Product Status
  • Table 31: Intraluminal Implantable Device - Product Description
  • Table 32: ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: GammaCore - Gastroenterology - Product Status
  • Table 34: GammaCore - Gastroenterology - Product Description
  • Table 35: gammaCore - Migraine Prevention - Product Status
  • Table 36: gammaCore - Migraine Prevention - Product Description
  • Table 37: GammaCore - Neurology - Product Status
  • Table 38: GammaCore - Neurology - Product Description
  • Table 39: GammaCore - Post-Traumatic Headache - Product Status
  • Table 40: GammaCore - Post-Traumatic Headache - Product Description
  • Table 41: GammaCore - Rheumatoid Arthritis - Product Status
  • Table 42: GammaCore - Rheumatoid Arthritis - Product Description
  • Table 43: GammaCore - Sjogren's Syndrome - Product Status
  • Table 44: GammaCore - Sjogren's Syndrome - Product Description
  • Table 45: Resolve Stimulator - Product Status
  • Table 46: Resolve Stimulator - Product Description
  • Table 47: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Aspire NP - Product Status
  • Table 49: Aspire NP - Product Description
  • Table 50: Centro Generator - Product Status
  • Table 51: Centro Generator - Product Description
  • Table 52: CentroSR Generator - Product Status
  • Table 53: CentroSR Generator - Product Description
  • Table 54: Equilia - Product Status
  • Table 55: Equilia - Product Description
  • Table 56: Griffin - Pulse Generator - Product Status
  • Table 57: Griffin - Pulse Generator - Product Description
  • Table 58: Intense Neuromodulation System - Heart Failure - Product Status
  • Table 59: Intense Neuromodulation System - Heart Failure - Product Description
  • Table 60: Microburst VNS Stimulator - Product Status
  • Table 61: Microburst VNS Stimulator - Product Description
  • Table 62: PhoenixRF SR - Product Status
  • Table 63: PhoenixRF SR - Product Description
  • Table 64: VITARIA System - Chronic Heart Failure - Product Status
  • Table 65: VITARIA System - Chronic Heart Failure - Product Description
  • Table 66: LivaNova PLC - Ongoing Clinical Trials Overview
  • Table 67: VITARIA System - Chronic Heart Failure - Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction
  • Table 68: Microburst VNS Stimulator - Microburst VNS Therapy Feasibility Study in Subjects with Refractory Epilepsy
  • Table 69: Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: Transcutaneous Auricular Vagus Nerve Stimulator (taVNS) - Product Status
  • Table 71: Transcutaneous Auricular Vagus Nerve Stimulator (taVNS) - Product Description

List of Figures

  • Figure 1: Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
  • Figure 2: Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
  • Figure 3: Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
  • Figure 4: Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
  • Figure 5: Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
Back to Top